MURRAY HILL, N.J.--(BUSINESS WIRE)-- C. R. Bard, Inc. (NYS: BCR) today announced that it has entered into a definitive agreement to acquire privately-held Neomend, Inc., a leading developer and ...

Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...

C. R. Bard announced that it has entered into a definitive agreement to acquire privately-held Neomend, a leading developer and supplier of sprayable surgical sealants and anti-adhesion products for a ...

C.R. Bard ($BCR) has agreed to pay $140 million up-front for Neomend, a California maker of products to seal air leaks in the lungs after surgery. The deal is ...

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received the European Union CE Mark for the company's ProGEL® PLATINUM Surgical ...

C.R. Bard, the Murray Hill, N.J., publicly traded medical device company, has acquired Neomend in a $140 million deal. Neomend, Irvine, Calif., which develops sprayable surgical sealants and ...

Neomend Inc., an Irvine medical products maker, said Wednesday that it has raised $30 million in a fourth round of funding. Clarus Ventures, a firm with offices in San Francisco and Boston, led the ...

Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...

Neomend markets the Progel ® Air Leak Sealant, which is the only FDA-approved product available for intraoperative sealing of air leaks following lung resection and has a CE mark for lung sealing and ...

Renowned medical devices maker CR Bard ( BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...